National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): all 537 studies

Page 1 of 6. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.

• Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs PlaceboNot yet recruitingNCT07683026Phase 2
• Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol SecretionRecruitingNCT07649317Phase 1
• Discovering Determinants of Food Intake by Application of Artificial Intelligence to Complex, High-Dimensional DataNot yet recruitingNCT07637656
• Longitudinal Immunophenotyping of Patients With Inflammatory Bowel DiseaseRecruitingNCT07619547
• Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid TumorsRecruitingNCT07444723Phase 2/3
• Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and AdultsNot yet recruitingNCT07388537
• Effects of Meal Macronutrients on Postprandial LipidsNot yet recruitingNCT07313787Phase 2
• Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGRecruitingNCT07216391Phase 2
• Hepatic Lipid Metabolism-Alcohol Use DisorderRecruitingNCT07191561
• Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes MellitusRecruitingNCT07142252Phase 2
• 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid CancerNot yet recruitingNCT06991738Phase 1/2
• Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort StudyRecruitingNCT06730113
• Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and MetabolismNot yet recruitingNCT06690294
• Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing SyndromeRecruitingNCT06635629Phase 2
• Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat ChangeRecruitingNCT06325722Not applicable
• Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric DoseRecruitingNCT06223555Not applicable
• Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic RateRecruitingNCT06044935Not applicable
• Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)RecruitingNCT05996536
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesRecruitingNCT05832229Phase 2
• Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell TransplantNot yet recruitingNCT05722210
• Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With ObesityNot yet recruitingNCT05713799Phase 2
• The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy ExpenditureRecruitingNCT05545306Not applicable
• Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin ResistanceRecruitingNCT05470504Phase 2
• Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With LipodystrophyRecruitingNCT05419037
• A Natural History Study of Metabolic Sizing in Health and DiseaseRecruitingNCT05398783
• Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity AssessmentRecruitingNCT05213598
• Evaluation of Patients With Gastrointestinal DiseaseRecruitingNCT05041374
• Natural History Study of Parathyroid DisordersRecruitingNCT04969926
• The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid CancerRecruitingNCT04927416Phase 2
• Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar IntakeRecruitingNCT04799301Phase 1
• Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research ApproachRecruitingNCT04685200
• Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)RecruitingNCT03884075Phase 2
• Study of Endocrine-Related Conditions and PhysiologyRecruitingNCT03867448
• The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid CancerRecruitingNCT03841617Phase 2
• Early Tracking of Childhood Health Determinants (ETCHED) StudyRecruitingNCT03481829
• Clinical and Molecular Characteristics of Primary Aldosteronism in BlacksRecruitingNCT03374215
• Evaluation of Adults With Endocrine and Metabolic-Related ConditionsRecruitingNCT02830308
• Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in MetabolismRecruitingNCT02692885
• Natural History of Noncirrhotic Portal HypertensionRecruitingNCT02417740
• Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing SyndromeRecruitingNCT02019706Phase 2
• New Heart Imaging Techniques to Evaluate Possible Heart DiseaseRecruitingNCT01399385Not applicable
• Clinical and Genetic Studies in Familial Non-medullary Thyroid CancerRecruitingNCT01109420
• Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingNCT00977977Phase 2
• Natural History of Familial Carcinoid TumorRecruitingNCT00646022
• Blood Sampling for Research Related to Sickle Cell DiseaseRecruitingNCT00542230
• Physical and Behavioral Traits of Overweight and Obese AdultsRecruitingNCT00428987
• Urinary Vitamin C Loss in Diabetic SubjectsRecruitingNCT00071526
• Genetic Studies of Insulin and DiabetesRecruitingNCT00001987
• Immune System Related Kidney DiseaseRecruitingNCT00001979
• Evaluation of Patients With Liver DiseaseRecruitingNCT00001971
• Diabetes and Heart Disease Risk in BlacksRecruitingNCT00001853
• Diagnosing and Treating Low Blood Sugar LevelsRecruitingNCT00001276
• Studies on Tumors of the ThyroidRecruitingNCT00001160
• Natural History of Thyroid Function DisordersRecruitingNCT00001159
• Vitamin E Dosing StudyCompletedNCT04801849Phase 2Results posted
• HOPE Consortium Trial to Reduce Pain and Opioid Use in HemodialysisCompletedNCT04571619Phase 2Results posted
• STOP-T1D Low-Dose (ATG)TerminatedNCT04291703Phase 2Results posted
• A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041CompletedNCT04279613Phase 1Results posted
• Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber)CompletedNCT04209075Phase 2Results posted
• Effects of Low Fat Versus Low Carbohydrate Diets on Energy MetabolismCompletedNCT03878108Not applicableResults posted
• Brain Dopamine Function in Human ObesityCompletedNCT03648892Early Phase 1Results posted
• Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda InterferonCompletedNCT03600714Phase 2Results posted
• Losartan for the Treatment of Pediatric NAFLDTerminatedNCT03467217Phase 2Results posted
• Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes MellitusTerminatedNCT03428945Phase 2Results posted
• Effect of Ultra Processed Versus Unprocessed Diets on Energy IntakeCompletedNCT03407053Not applicableResults posted
• Title: Therapeutic Targets in African-American Youth With Type 2 DiabetesCompletedNCT02960659Phase 1/2Results posted
• Food Intake Response to Short-Term Modifications of Metabolism in HumansCompletedNCT02939404Not applicableResults posted
• Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label ExtensionCompletedNCT02639286Phase 2Results posted
• Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)CompletedNCT02580877Phase 2Results posted
• Treatment of Chronic Delta Hepatitis With Lonafarnib and RitonavirCompletedNCT02511431Phase 2Results posted
• Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816CompletedNCT02468648Phase 2Results posted
• Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor MutationsCompletedNCT02457897Phase 2Results posted
• Add-on Peginterferon Following Nucleos(t)Ide Analogue TreatmentCompletedNCT02364336Phase 2Results posted
• ATG-GCSF in New Onset Type 1 DiabetesCompletedNCT02215200Phase 2Results posted
• Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis CCompletedNCT02118012Phase 1/2Results posted
• Investigation of the Gut Microbiota in Regulating Nutrient Absorption in HumansCompletedNCT02037295Phase 2Results posted
• Study of Human Non-Shivering Thermogenesis and Basal Metabolic RateCompletedNCT01950520Phase 2Results posted
• New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis CCompletedNCT01888900Phase 2Results posted
• HALT Progression of Polycystic Kidney Disease Study BCompletedNCT01885559Phase 3Results posted
• Predicting Adherence to a Heart-Healthy Diet in Lean and Obese IndividualsCompletedNCT01862796Not applicableResults posted
• Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary AtresiaCompletedNCT01854827Phase 1/2Results posted
• Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin ECompletedNCT01792115Phase 2Results posted
• Short-term Effects of Leptin in People With LipodystrophyCompletedNCT01778556Phase 2Results posted
• CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1CompletedNCT01773707Phase 2Results posted
• Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in ChildrenCompletedNCT01529268Phase 2/3Results posted
• Lonafarnib for Chronic Hepatitis DCompletedNCT01495585Phase 2Results posted
• Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis BCompletedNCT01369212Phase 3Results posted
• Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis BTerminatedNCT01369199Phase 3Results posted
• Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT01368497Phase 3Results posted
• Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained MenCompletedNCT01294319Phase 2Results posted
• The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)CompletedNCT01265498Phase 2Results posted
• Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin TrialCompletedNCT01149369Phase 2Results posted
• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"CompletedNCT01030861Phase 2Results posted
• Canakinumab Study in Individuals With Newly Diagnosed Type 1 DiabetesCompletedNCT00947427Phase 2Results posted
• A Lifestyle Change Program to Prevent Type 2 DiabetesCompletedNCT00886340Phase 2Results posted
• The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese SubjectsCompletedNCT00856609Phase 3Results posted
• Reduced Carbohydrate Versus Fat in Obese SubjectsCompletedNCT00846040Phase 2Results posted
• Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesTerminatedNCT00837759Phase 2Results posted
• Nortriptyline for Idiopathic GastroparesisCompletedNCT00765895Phase 3Results posted
• High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1CompletedNCT00735969Phase 2Results posted

← National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) overview and focus areas